ARTICLE | Company News
Anchor Therapeutics, Kyowa Hakko Kirin deal
August 6, 2012 7:00 AM UTC
The companies partnered to use Anchor's pepducin technology to advance Kyowa's GPCR drug discovery portfolio. The partners will also develop pepducin therapeutics and use the pepducin technology to co...